ALB and neoplasm: Moreover, given the limitations of in vitro settings, especially for evaluating complex molecular pathways within the entire tumor microenvironment and the exploitation of HSA as the natural carrier of NBs, a preclinical in vivo assessment will be crucial to solidify the potential of our proposed approach.